GILD vs PFIS · P/E 18, rev $7.80B vs P/E 11, rev $132.5M
Gilead Sciences Inc (GILD) versus Peoples Fin (PFIS) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Peoples Fin (PFIS) is a banks - regional company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported PFIS revenue for 2026-06-30 was $132.5M. Net income was $29.6M. PFIS currently screens at market cap $618.6M and trailing P/E 10.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. PFIS currently screens at market cap $618.6M and trailing P/E 10.5.
Not investment advice. Open the GILD and PFIS stock pages for the full models.
Not investment advice.